Assessing and managing persistent delirium in older patients with Parkinson's disease
Parkinson's Disease: Risk Assessment of Persistent Delirium and Its Management
This study looks at older people with Parkinson's disease who have had ongoing confusion for two weeks or more to see what might cause it and how they are currently being cared for.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 217 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Newcastle University Academic / other |
| Locations | 1 site (Keighley, West Yorkshire) |
| Trial ID | NCT05437458 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on older individuals (65 years and older) diagnosed with Parkinson's disease who have experienced persistent delirium lasting 14 days or more. It aims to identify risk factors associated with persistent delirium and evaluate the management strategies currently in place. The methodology includes a retrospective review of case notes and qualitative interviews with participants and their carers to gather insights on their experiences. The goal is to enhance understanding of delirium in this population and improve care strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 65 and above with a diagnosis of idiopathic Parkinson's disease who have experienced persistent delirium.
Not a fit: Patients who are younger than 65 or do not have a diagnosis of Parkinson's disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better identification and management of delirium in older patients with Parkinson's, potentially reducing adverse outcomes.
How similar studies have performed: While there is limited research specifically targeting this demographic, studies on delirium management in older adults have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion Criteria for People with Parkinson's: 1. Participants must be aged at least 65 years old in 2015. 2. Participants must have a diagnosis of idiopathic Parkinson's disease using Queen's Square Brain Bank criteria (32) diagnosed by a movement disorders expert. 3. Admitted patients must have stayed in hospital \>24 hours for at least one hospital admission. 4. Participants must have had previous admissions/attendance to the hospital between 2015-2019. 5. An appropriate consultee must be available and willing to be involved in this study for potential participants without the mental capacity to consent to the extraction of information from their medical records. 6. For the qualitative study, participants must have the mental capacity to consent and must have been affected by persistent delirium. The participant must be able to understand, write and speak English. Inclusion Criteria for Carers in the Qualitative Study 1. Participants must be aged 18 or over. 2. Participants must have the mental capacity to consent. 3. Participants must have been a primary carer for someone living with Parkinson's, who has had a previous experience of persistent delirium, during 2015-2020. 4. Participants must be able to understand, write and speak English. Exclusion Criteria: Exclusion Criteria for People with Parkinson's 1. Aged less than 65 years old in 2015. 2. Diagnosed with drug-induced parkinsonism, vascular parkinsonism, atypical Parkinsonian disorder (e.g. progressive supranuclear palsy, multiple systems atrophy, corticobasal syndrome) or dementia (e.g. dementia with Lewy bodies, vascular dementia, Alzheimer's disease). 3. Potential participants will be excluded from the interview if they cannot communicate verbally or cannot read/write in English. 4. The potential participant's medical records are incomplete and no alternate strategies are appropriate to account for the missing data, without introducing significant study bias or inaccuracy in statistical findings. Criteria for when the medical records will be excluded in the analysis will be: 1. There is uncertainty regarding the identity of the medical records. 2. Documentation for the admission of interest is missing to the extent that researchers are unable to extract the relevant data required for the aims of this study. 5) For the qualitative study, potential participants will be excluded if they do not have the mental capacity to consent. 6) Potential participants without a consultee and also do not have the mental capacity to consent to this study. 7) Potential deceased participants will be excluded if there is previous documentation that the person would not have wanted to participate in research studies. Exclusion Criteria for Carers in the Qualitative Study 1. The potential participant is aged less than 18 years old. 2. The potential participant does not have the mental capacity to consent to this study. 3. The potential participant is not the primary carer for someone with Parkinson's and has been affected by persistent delirium, during 2015-2020. 4. The potential participant does not understand, write and/or speak English. 5. The potential participant has a severe speech impairment to the extent that the audio recording of the interview is unintelligible. -
Where this trial is running
Keighley, West Yorkshire
- Airedale Hospital — Keighley, West Yorkshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: William Lee, MB/BS — Airedale Hospital
- Study coordinator: William Lee, MB/BS
- Email: william.lee4@nhs.net
- Phone: 01535 652511
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.